Defined structure. Reproducible performance. Reliable supply.
Controlled liposomal systems supplied as functional inputs for partner formulation and manufacturing programmes.
GMPriority Pharma manufactures bulk liposomal systems for brands, manufacturers and ingredient partners requiring controlled liposomal inputs for integration into formulation and manufacturing programmes.
Produced within GMP-certified, FSSC ISO 22000-accredited UK facilities, these systems are developed and manufactured using defined processing parameters to support consistency, compatibility and scalable supply.
Bulk liposomal ingredients are supplied as controlled functional inputs, not generic ingredients.
Each ingredient is developed with defined structural and processing parameters to ensure predictable behaviour when integrated into downstream formulations and manufacturing environments.
This enables partners to work with liposomal systems that are:
Delivery is designed with manufacturing in mind.
GMPriority Pharma supplies both liquid and dry-format liposomal systems, designed to support different formulation and manufacturing requirements.
Bulk supply provides access to liposomal ingredient formats suitable for integration into:
Liquid Systems
Hydrated liposomal dispersions suitable for direct integration into liquid formulations or further processing.
Dry Systems
Solid-state liposomal formats produced through controlled drying processes, enabling:
Each format is defined by controlled composition, processing parameters and structural targets to ensure consistent behaviour across applications.
Liposomal ingredients are highly sensitive to formulation and processing conditions, with performance dependent on particle size distribution, dispersion behaviour and structural integrity.
Uncontrolled or variable inputs can lead to instability, inconsistency and reformulation challenges within finished products.
GMPriority Pharma manufactures liposomal systems within defined and repeatable parameters, ensuring that materials behave consistently when integrated into partner formulations.
Defined liposomal processing protocols
Structured batch production
Controlled environmental conditions
Integrated, rigorous quality systems
Production is governed by defined processing parameters, in-process controls and batch traceability systems to maintain reproducibility at scale.
Bulk liposomal systems are supplied to support a range of technically aligned partner models including:
This model provides flexibility for partners requiring controlled liposomal inputs with finished product manufacture or brand constraints.
Bulk liposomal systems are typically supplied where:
Formulation is defined but requires controlled liposomal input
Manufacturing is carried out by partner or third-party facilities
Ingredient-level consistency is critical to finished product performance
This model supports partners seeking to retain control of formulation or manufacturing while relying on GMPriority Pharma for delivery system production.
Bulk supply is not speculative sourcing, it is structured, controlled production from an established liposomal manufacturing environment.
Controlled liposomal systems designed for integration, compatibility and long-term commercial supply.